ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT) explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT) trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could early tube feeding after stem cell transplant prevent deadly gut complications?
Disease control Not yet recruitingThis study looks at whether starting tube feeding right after a stem cell transplant can lower the risk of severe gut graft-versus-host disease (GVHD) in people with blood cancers or serious blood disorders. About 112 participants will be randomly assigned to either standard nutr…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 26, 2026 09:41 UTC
-
New study to track how stem cell treatment impacts daily movement
Knowledge-focused Not yet recruitingThis study will follow 140 adults receiving a donor stem cell transplant to see how their physical abilities change over time. Researchers will measure walking, balance, strength, and fitness using simple tests. The goal is to better understand the treatment's effects on daily fu…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)
Sponsor: University of Dublin, Trinity College • Aim: Knowledge-focused
Last updated May 26, 2026 09:27 UTC